← Browse by Condition
Medical Condition

advanced nsclc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06751901 Phase 2
Recruiting

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Enrollment
10 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →